Sebastian Aguiar, geroscientist and Venture Fellow at Apollo Ventures, delivers the Lord Florey Lecture at Lincoln College, Oxford in November 2018. H...
What’s new in media and industry: Who’s who in longevity, and more
Here’s our handpicked selection of the best interviews, blog posts, popular articles, and breaking biotech news of the last two weeks: Want a systemat...
What’s new in media and industry: Huge piles of money, and more
Here’s our handpicked selection of the best blog posts, popular articles, and breaking biotech news of the last two weeks: Longevity enthusiasts...
This chip can pluck the bad apples out of your blood
Many years from now, you’re reclining in one of the many gray-blue armchairs that line the walls of a clinic. Your arm is propped up on a collapsible ...
James Peyer: Why primary indications matter
“Aging” isn’t a disease as recognized by the FDA–not yet anyway. But then how will the companies trialing anti-aging drugs eve...
What’s new in media and industry: Laura Deming’s intro to longevity, and more
Just getting started around here, or want to introduce someone new to the world of longevity science? This handy primer from Laura Deming (of Longevit...
James Peyer: Navigating the “Biotech Valley of Death”
Ever hear about an exciting discovery in the biomedical world, then later wonder why it seemingly dropped off the face of the Earth? In fact, it’...
Merry Media, And A Happy New Year
We want you! Reason over at Fight Aging! lists nine promising approaches to rejuvenation therapy that he’d like to see in the very near future: ...
Video interview with James Peyer: Longevity science from bench to clinic, and everything in between
No one should have to read during the holidays. That’s why we made you a video! I spoke to our own James Peyer about how he got started in the l...
A peek inside the companies using AI to combat aging
Last Wednesday I attended the Buck Institute’s workshop on AI and Longevity, where speakers from several different organizations discussed how t...